<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001053369
<NAME>                        ELITE PHARMACEUTICALS INC /DE/
<MULTIPLIER>                                   1
<CURRENCY>                                     Dollar

<S>                                             <C>
<PERIOD-TYPE>                                   6-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   SEP-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         2,973,481
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               20,292,742
<PP&E>                                         3,095,431
<DEPRECIATION>                                 505,151
<TOTAL-ASSETS>                                 24,711,924
<CURRENT-LIABILITIES>                          12,253,507
<BONDS>                                        2,765,000
                          0
                                    0
<COMMON>                                       89,150
<OTHER-SE>                                     9,604,267
<TOTAL-LIABILITY-AND-EQUITY>                   24,711,924
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  1,144,629
<OTHER-EXPENSES>                               12,015,000
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             115,507
<INCOME-PRETAX>                               (13,154,640)
<INCOME-TAX>                                   1,255
<INCOME-CONTINUING>                           (13,155,895)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                  (13,155,895)
<EPS-BASIC>                                   (1.48)
<EPS-DILUTED>                                 (1.48)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission